Evidence map›Paper›PMID 27567921›Full record

ArticleNeuromolecular medicine2017

The Effects of Alpha Boswellic Acid on Reelin Expression and Tau Phosphorylation in Human Astrocytes.

Esmat Fathi, Fatemeh Hedayati Katouli, Gholam Hossein Riazi, Marzieh Dehghan Shasaltaneh, Elham Parandavar, Samaneh Bayati, Ali Afrasiabi, Reza Nazari

Abstract read
PubMed Publisher
In one paragraph

Article in Neuromolecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The journey of boswellic acids from synthesis to pharmacological activities.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Esmat FathiInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Fatemeh Hedayati KatouliInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Gholam Hossein RiaziInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran. ghriazi@ut.ac.ir.
Marzieh Dehghan ShasaltanehInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Elham ParandavarInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Samaneh BayatiInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Ali AfrasiabiInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Reza NazariInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
University of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reelin is an extracellular glycoprotein which contributes to synaptic plasticity and function of memory in the adult brain. It has been indicated that the Reelin signaling cascade participates in Alzheimer's disease (AD). Besides the neurons, glial cells such as astrocytes also express Reelin protein. While functional loss of astrocytes has been reported to be associated with AD, dysfunction of astrocytic Reelin signaling pathway has not received much attention. Therefore, we investigated the effects of α-boswellic acid (ABA) as one of the major component of Boswellia serrata resin on primary fetal human astrocytes under a stress paradigm as a possible model for AD through study on Reelin cascade. For this aim, we used streptozotocin (STZ), in which from an outlook generates Alzheimer's hallmarks in astrocytes, and assayed Reelin expression, Tau and Akt phosphorylation as well as reactive oxygen species (ROS) generation and apoptosis in the presences of ABA. Our results indicated that while STZ (100 µM) down-regulated the expression of Reelin, ABA (25 µM) up-regulated its expression (p < 0.01) for 24 h. ABA efficiently reduced hyperphosphorylated Tau (Ser404) in STZ-treated astrocytes (p < 0.01). Furthermore, STZ-induced apoptosis by increasing cleaved caspase three (p < 0.01) and ROS generation (p < 0.01), a further pathological hallmark of Tauopathy. On the other hand, ABA decreased ROS generation and promoted proliferation of astrocytes through elevating Survivin expression (p < 0.01). These results showed that ABA could be considered as a potent therapeutic agent for prevention and decreasing the progression of Alzheimer's hallmarks in astrocytes; however, more in vivo studies would be needed.

Indexed as

ApoptosisAstrocytesCell Adhesion Molecules, NeuronalCells, CulturedCerebral CortexExtracellular Matrix ProteinsGene Expression RegulationHumansHypothalamusInhibitor of Apoptosis ProteinsNerve Tissue ProteinsOxidative StressPentacyclic TriterpenesPhosphorylationPhosphoserinePrimary Cell CultureAKT1 protein, humanBIRC5 protein, humanCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsInhibitor of Apoptosis ProteinsMAPT protein, humanNerve Tissue ProteinsPentacyclic TriterpenesPhosphoserineProto-Oncogene Proteins c-aktReactive Oxygen SpeciesReelin ProteinRELN protein, humanSerine EndopeptidasesStreptozocinSurvivintau ProteinsAlpha boswellic acidAlzheimer’s diseaseAstrocytesReelinStreptozotocinTau

Identifiers

PMID27567921
OpenAlexW2507668037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.